Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
about
Wnt/β-catenin signalling in prostate cancerDifferential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptorGroove Binding of Vanillin and Ethyl Vanillin to Calf Thymus DNA.Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells.In vitro evaluation of anticancer potentials of lupeol isolated from Elephantopus scaber L. on MCF-7 cell lineBMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cellsCastration-resistant prostate cancer: potential targets and therapies.Experimental evidence of persistent androgen-receptor-dependency in castration-resistant prostate cancer.PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinomaAndrogen receptor modulators: a marriage of chemistry and biology.Potential targets in the discovery of new hair growth promoters for androgenic alopecia.Comparative binding mechanism of lupeol compounds with plasma proteins and its pharmacological importance.Lupeol and Its Role in Chronic Diseases.The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor.Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
P2860
Q28269116-D8766CDF-CC7C-4784-A636-AB23363BB794Q28534575-20F607B7-3075-4966-AFD6-1881417B5D6EQ32176263-89DE018E-FC75-4AC6-BB55-3CD9519E1485Q34283730-71A861C8-31CA-4D00-BC0E-CC106F41521CQ34432344-75B0A99D-3A23-47E2-9B58-19220DABF687Q34544617-9291EE59-D69D-42BC-A539-9DF9050FA7B2Q34720367-9640163C-44D4-4E2F-A60D-086803FB5431Q36002945-8517C6DB-906F-4D6D-9339-C610C5DA5ACDQ36196682-7370820C-932D-4ECB-9F71-CCC3ECF00841Q37139070-CCF4EFEF-C103-45C4-A10F-2C60BCEC9515Q37323327-05A60255-63A5-4F53-BFD6-60A35D68F6A1Q38116575-8458F770-A798-4541-BFE6-952381DEEA4CQ38215774-DE208D37-11AF-474C-A0F0-661FA60747F8Q38906597-0F186C63-9EB1-45B4-BDA7-B015911861BAQ38988572-2C242D8F-1059-43DA-BCC8-5B443FAE2CA1Q42969892-92071F10-AFA4-4846-A2CA-46D7860CD6E9Q53197134-0B392EA2-32E8-4D22-AA37-8C168B631D7BQ53215494-D6AF518E-7961-49FA-8251-EBEF269E3027
P2860
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
@en
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
@nl
type
label
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
@en
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
@nl
prefLabel
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
@en
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
@nl
P2860
P1476
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy
@en
P2093
R Jeffery Karnes
Shrawan Kumar Mishra
P2860
P304
P356
10.1158/1078-0432.CCR-11-0916
P407
P577
2011-06-28T00:00:00Z